ArsenalBio Announces Presentation of Six Abstracts at AACR Annual Meeting Highlighting Programmable

Company to share preclinical data on the use of integrated circuit T cells for the development of cell therapies for the treatment of kidney and other solid tumor cancersSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#AACR23--Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company e...

Related Keywords

United States ,American ,Gwen Gordon ,Ken Drazan ,Arsenal Biosciences Inc ,Linkedin ,American Association For Cancer Research ,Arsenalbio Co ,Facebook ,Arsenal Biosciences ,American Association ,Cancer Research ,Chief Executive ,Breaking Research ,Adoptive Cell ,Natural Killer Cell ,Synthetic Pathway Activators ,Lead Identification ,Silico Drug ,South San Francisco ,